1. Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition
    Lynnette R. Ferguson et al, 2015, Seminars in Cancer Biology CrossRef
  2. A Novel Pathogenic BRCA1 Splicing Variant Produces Partial Intron Retention in the Mature Messenger RNA
    Maria Esposito et al, 2016, IJMS CrossRef
  3. The Inherited Bone Marrow Failure Syndromes
    S. Deborah Chirnomas et al, 2013, Pediatric Clinics of North America CrossRef
  4. Clinical and genetic characterization of hereditary breast cancer in a Chinese population
    Wenjing Jian et al, 2017, Hered Cancer Clin Pract CrossRef
  5. Are VNTRs co-localizing with breast cancer-associated SNPs?
    Martin Leclerc et al, 2017, Breast Cancer Res Treat CrossRef
  6. Triptolide reduces proliferation and enhances apoptosis of human non-small cell lung cancer cells through PTEN by targeting miR-21
    XIAOFANG LI et al, 2016 CrossRef
  7. Molecular biology of gynecological cancer
    KENZO SONODA, 2016 CrossRef
  8. Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases
    Nathan A Berger et al, 2018, British Journal of Pharmacology CrossRef
  9. DNA and RNA Quadruplex-Binding Proteins
    Václav Brázda et al, 2014, IJMS CrossRef
  10. Identification of genetic variants for clinical management of familial colorectal tumors
    Mev Dominguez-Valentin et al, 2018, BMC Med Genet CrossRef
  11. Hereditary Nonpolyposis Colorectal Cancer and Cancer Syndromes: Recent Basic and Clinical Discoveries
    Erbao Chen et al, 2018, Journal of Oncology CrossRef
  12. Saliva samples as a source of DNA for high throughput genotyping: an acceptable and sufficient means in improvement of risk estimation throughout mammographic diagnostics
    U. G. Poehls et al, 2018, Eur J Med Res CrossRef
  13. Evaluation of MLH1 variants of unclear significance
    Nicole Köger et al, 2018, Genes Chromosomes Cancer CrossRef
  14. null
    Karin Alvarez et al, 2018 CrossRef
  15. Integrating the DNA damage and protein stress responses during cancer development and treatment
    Vassilis G Gorgoulis et al, 2018, J. Pathol. CrossRef
  16. null
    W. Wei et al, 2016 CrossRef
  17. A portrait of germline mutation in Brazilian at-risk for hereditary breast cancer
    Ana Rafaela de Souza Timoteo et al, 2018, Breast Cancer Res Treat CrossRef
  18. The Swr1 chromatin-remodeling complex prevents genome instability induced by replication fork progression defects
    Anjana Srivatsan et al, 2018, Nat Commun CrossRef
  19. A multi-gene panel beyond BRCA1/BRCA2 to identify new breast cancer-predisposing mutations by a picodroplet PCR followed by a next-generation sequencing strategy: a pilot study
    Marcella Nunziato et al, 2018, Analytica Chimica Acta CrossRef
  20. Small-Molecule Inhibitors Targeting DNA Repair and DNA Repair Deficiency in Research and Cancer Therapy
    Sarah R. Hengel et al, 2017, Cell Chemical Biology CrossRef
  21. Committee Opinion No. 693
    , 2017, Obstetrics & Gynecology CrossRef
  22. “Don’t stop believing!” From health religiosity to an equality-enhancing hermeneutic of health promotion
    Britta Pelters et al, 2018, International Journal of Qualitative Studies on Health and Well-being CrossRef
  23. Germline variants of BRCA1 and BRCA2 genes in population of Voronezh region of Russian Federation and their association with risk of breast cancer
    Sergei A. Solodskikh et al, 2018, Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis CrossRef
  24. Racial/Ethnic Disparities in BRCA Counseling and Testing: a Narrative Review
    Christina D. Williams et al, 2019, J. Racial and Ethnic Health Disparities CrossRef
  25. BRCA1 and BRCA2 mutations sensitize to chemotherapy in patient-derived pancreatic cancer xenografts
    I Lohse et al, 2015, Br J Cancer CrossRef
  26. A genetic network that suppresses genome rearrangements in Saccharomyces cerevisiae and contains defects in cancers
    Christopher D. Putnam et al, 2016, Nat Commun CrossRef
  27. null
    Hiroshi Kobayashi, 2017 CrossRef
  28. Optimizing recruitment to a prostate cancer surveillance program among male BRCA1 mutation carriers: invitation by mail or by telephone
    Anna Galor et al, 2013, Hered Cancer Clin Pract CrossRef
  29. Global celebrities' effect on health awareness among Jordanians: A study using the case of Angelina Jolie
    Maysa Al‐Hussaini et al, 2019, Jrnl of Gene Coun CrossRef
  30. Somatic mutation load of estrogen receptor-positive breast tumors predicts overall survival: an analysis of genome sequence data.
    Svasti Haricharan et al, 2014, Breast Cancer Res Treat CrossRef
  31. KIF14 Promotes AKT Phosphorylation and Contributes to Chemoresistance in Triple-Negative Breast Cancer
    Stina M. Singel et al, 2014, Neoplasia CrossRef
  32. Breast Cancer
    Javed Akhter et al, 2014, Advances In Anatomic Pathology CrossRef
  33. Essential Saccharomyces cerevisiae genome instability suppressing genes identify potential human tumor suppressors
    Anjana Srivatsan et al, 2019, Proc Natl Acad Sci USA CrossRef
  34. RAD51BActivity and Cell Cycle Regulation in Response to DNA Damage in Breast Cancer Cell Lines
    Phoebe S. Lee et al, 2014, Breast Cancer�(Auckl) CrossRef
  35. A DNA repair variant in POLQ (c.-1060A > G) is associated to hereditary breast cancer patients: a case–control study
    Ana Paula Carneiro Brandalize et al, 2014, BMC Cancer CrossRef
  36. Validation of an NGS Approach for Diagnostic BRCA1/BRCA2 Mutation Testing
    Daniela Dacheva et al, 2015, Mol Diagn Ther CrossRef
  37. Spectrum and frequencies of BRCA1/2 mutations in Bulgarian high risk breast cancer patients
    Rumyana Ivanova Dodova et al, 2015, BMC Cancer CrossRef
  38. null
    Michel Neidhart, 2016 CrossRef
  39. Screening of BRCA1/2 Mutations Using Direct Sequencing in Indonesian Familial Breast Cancer Cases
    Sumadi Lukman Anwar et al, 2016, Asian Pacific Journal of Cancer Prevention CrossRef
  40. Investigation of breast cancer sub-populations in black and white women in South Africa
    Caroline Dickens et al, 2016, Breast Cancer Res Treat CrossRef
  41. Blocking protein quality control to counter hereditary cancers
    Caroline Kampmeyer et al, 2017, Genes Chromosomes Cancer CrossRef
  42. A survey of the clinicopathological and molecular characteristics of patients with suspected Lynch syndrome in Latin America
    Benedito Mauro Rossi et al, 2017, BMC Cancer CrossRef
  43. null
    Natalia Jančárková, 2017 CrossRef
  44. Metabolomics reveals novel blood plasma biomarkers associated to the BRCA1-mutated phenotype of human breast cancer
    Bàrbara Roig et al, 2017, Sci Rep CrossRef
  45. Increased Cancer Prevalence in Peripartum Cardiomyopathy
    Tobias J. Pfeffer et al, 2019, JACC: CardioOncology CrossRef
  46. Role of Rad51 and DNA repair in cancer: A molecular perspective
    Erik Laurini et al, 2020, Pharmacology & Therapeutics CrossRef
  47. null
    Wenhao Jiang et al, 2019 CrossRef
  48. Double Mutation of Apc and Brca1 in an Italian Family
    Maria Teresa Vietri et al, 2020, Cancer Genetics CrossRef
  49. “Back to a false normality”: new intriguing mechanisms of resistance to PARP inhibitors
    Lorena Incorvaia et al, 2017, Oncotarget CrossRef
  50. The clinical value of aberrant epigenetic changes of DNA damage repair genes in human cancer
    Dan Gao et al, 2016, Oncotarget CrossRef
  51. Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention
    Nicole M. Davis et al, 2014, Oncotarget CrossRef
  52. Early diagnosis of breast and ovarian cancers by body fluids circulating tumor-derived exosomes
    Leyla Norouzi-Barough et al, 2020, Cancer Cell Int CrossRef
  53. Hereditary Predisposition to Prostate Cancer: From Genetics to Clinical Implications.
    Andreia Brandão et al, 2020, Int J Mol Sci CrossRef
    L. Rybchenko et al, 2019, Probl Radiac Med Radiobiol CrossRef
  55. Germline Genetic Findings Which May Impact Therapeutic Decisions in Families with a Presumed Predisposition for Hereditary Breast and Ovarian Cancer
    Carolina Velázquez et al, 2020, Cancers CrossRef
  56. DNA damage repair as a target in pancreatic cancer: state-of-the-art and future perspectives
    Lukas Perkhofer et al, 2020, Gut CrossRef
  57. null
    Taher Dehkharghanian et al, 2020 CrossRef
  58. GT198 (PSMC3IP) germline variants in early-onset breast cancer patients from hereditary breast and ovarian cancer families
    Stephanie Schubert et al, 2017, Genes Cancer CrossRef
  59. Risk Factors for Ipsilateral Breast Tumor Recurrence in Triple-Negative or HER2-Positive Breast Cancer Patients Who Achieve a Pathologic Complete Response After Neoadjuvant Chemotherapy
    Makoto Ishitobi et al, 2020, Ann Surg Oncol CrossRef
  60. CTLA-4 Blockade Synergizes Therapeutically with PARP Inhibition in BRCA1-Deficient Ovarian Cancer
    Tomoe Higuchi et al, 2015, Cancer Immunol Res CrossRef
  61. Improved Therapeutic Window in BRCA-mutant Tumors with Antibody-linked Pyrrolobenzodiazepine Dimers with and without PARP Inhibition
    Haihong Zhong et al, 2019, Mol Cancer Ther CrossRef
  62. Challenges of Genomic Testing for Hereditary Breast and Ovarian Cancers
    Lindsey McAlarnen et al, 2021, TACG CrossRef
  63. Prevalence of mutations in BRCA and MMR genes in patients affected with hereditary endometrial cancer.
    Maria Teresa Vietri et al, 2021, Med Oncol CrossRef
  64. Effect of risk-reducing salpingo-oophorectomy on quality of life in Korean BRCA mutation carriers
    Sumin Chae et al, 2021, Asian Journal of Surgery CrossRef
  65. Multiethnic PDX models predict a possible immune signature associated with TNBC of African ancestry.
    Evelyn M Jiagge et al, 2021, Breast Cancer Res Treat CrossRef
  66. Rare germline variants in DNA repair-related genes are accountable for papillary thyroid cancer susceptibility
    Catia Mio et al, 2021, Endocrine CrossRef
  67. null
    Bernardo Bonanni et al, 2020 CrossRef
  68. Current update on the molecular genetics and management of hereditary ovarian cancers: a primer for radiologists
    Malak Itani et al, 2021, Abdom Radiol CrossRef
  69. DNA damage response and repair in pancreatic cancer development and therapy
    Parnia Rahnamay Farnood et al, 2021, DNA Repair CrossRef
  70. null
    , 2021 CrossRef
  71. In-Silico Analyses of Nonsynonymous Variants in the BRCA1 Gene
    Sidra Arshad et al, 2021, Biochem Genet CrossRef
  72. null
    Sue K. Park et al, 2021 CrossRef
  73. Co-occurrence and mutual exclusivity: what cross-cancer mutation patterns can tell us
    Geniver El Tekle et al, 2021, Trends in Cancer CrossRef
  74. Are there monogenic hereditary forms of bladder cancer or only genetic susceptibilities?
    Tarek Souaid et al, 2021, Pharmacogenomics CrossRef
  75. null
    Igor Kovalchuk, 2021 CrossRef
  76. Overview of Ferroptosis and Synthetic Lethality Strategies
    Yuko Kinowaki et al, 2021, IJMS CrossRef
  77. Identification and Characterization of New Alu Element Insertion in the BRCA1 Exon 14 Associated with Hereditary Breast and Ovarian Cancer
    Ahmed Bouras et al, 2021, Genes CrossRef
  78. Identification and Characterization of an Exonic Duplication in PALB2 in a Man with Synchronous Breast and Prostate Cancer
    Ahmed Bouras et al, 2022, IJMS CrossRef
  79. Clinical significance of gene polymorphisms for hereditary predisposition to breast and ovarian cancer (review of literature)
    D. I. Vodolazhsky et al, 2021, Klin. lab. diagn. CrossRef
  80. An update on the safety of olaparib for treating ovarian cancer
    Kelsi Cottrell et al, 2022, Expert Opinion on Drug Safety CrossRef
  81. Management of Colorectal Cancer in Hereditary Syndromes
    Lisa A. Cunningham et al, 2022, Surgical Oncology Clinics of North America CrossRef
  82. Whole genome sequencing identifies rare genetic variants in familial pancreatic cancer patients
    Ming Tan et al, 2022, Annals of Human Genetics CrossRef
  83. Outcomes of Concurrent Prophylactic Mastectomy and Oophorectomy, Compared to Mastectomy and Hysterectomy, in Hereditary Breast and Gynecologic Cancer: A National Surgical Quality Improvement Program Database Analysis
    Ai-Lien Le et al, 2022, Journal of Gynecologic Surgery CrossRef
  84. Spectrum of BRCA1/2 Mutations in Romanian Breast and Ovarian Cancer Patients
    Radu Vidra et al, 2022, IJERPH CrossRef
  85. Breast Cancer Induced by X-Ray Mammography Screening? A Review Based on Recent Understanding of Low-Dose Radiobiology
    Ernest K.J. Pauwels et al, 2016, Med Princ Pract CrossRef
  86. Familial history and prevalence of BRCA1, BRCA2 and TP53 pathogenic variants in HBOC Brazilian patients from a public healthcare service
    Bruna Palma Matta et al, 2022, Sci Rep CrossRef
  87. Gene Mutations in Hereditary Breast Cancer- A Review
    Pathima Fairoosa et al, 2020, EJMED CrossRef
  88. Overview on population screening for carriers with germline BRCA mutation in China
    Huijun Lei et al, 2022, Front. Oncol. CrossRef
  89. Identification of novel exonic variants contributing to hereditary breast and ovarian cancer in West Indian population
    Bhargav N. Waghela et al, 2022, Gene CrossRef
  90. Changes of Mutations and Copy‐Number and Enhanced Cell Migration during Breast Tumorigenesis
    Seung Hyuk T. Lee et al, 2022, Advanced Biology CrossRef
  91. Functional characterization of MLH1 missense variants unveils mechanisms of pathogenicity and clarifies role in cancer
    Marwa Mahdouani et al, 2022, PLoS ONE CrossRef
  92. Through the Looking Glass: Updated Insights on Ovarian Cancer Diagnostics
    Sourav Chakraborty et al, 2023, Diagnostics CrossRef
  93. Frequency and distribution of BRCA1/BRCA2 large genomic rearrangements in Turkish population with breast cancer
    Tugba Akin Duman et al, 2023, J Hum Genet CrossRef
  94. Precision oncology comes of age
    Steven Sorscher, 2023 CrossRef
  95. Cancer Risk Assessment and Screening; A Challenge for Clinical Pathology Service?
    Siti Boedina Kresno, 2020, Indonesian J. Clin. Pathol. Med. Lab. CrossRef
  96. Radiosensitivity and early onset cancer
    K H Chadwick, 2023, J. Radiol. Prot. CrossRef
  97. Overview of the Genetic Causes of Hereditary Breast and Ovarian Cancer Syndrome in a Large French Patient Cohort
    Ahmed Bouras et al, 2023, Cancers CrossRef
  98. Hereditary breast and ovarian cancer: from genes to molecular targeted therapies
    Giovanni Ponti et al, 2023, Critical Reviews in Clinical Laboratory Sciences CrossRef
  99. Possible impact of HLA class I and class II on malignancies driven by a single germ‐line BRCA1 mutation
    Milena Ivanova et al, 2023, Int J Immunogenetics CrossRef
    Anisse Marques Chami et al, 2023, MPJ CrossRef
  101. Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: a multicenter study in Taiwan
    Siao Muk Cheng et al, 2024, J Biomed Sci CrossRef
  102. Molecular characterization as new driver in prognostic signatures and therapeutic strategies for endometrial cancer
    Elisa D'Agostino et al, 2024, Cancer Treatment Reviews CrossRef